AzTrials
AzTrials

Magnetic Resonance ImagingMAP-VSNCT03152539

Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers

A study testing MRI, EEG and NIRS in people with Magnetic Resonance Imaging, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of the studies that will be carried out on volunteer patients who have given their consent will be the development and optimization of the sequence parameters or the design of the stimulation paradigms in order to optimize the quality and Relevance of the images realized taking into account… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Magnetic Resonance Imaging
What is being tested?
MRI, EEG and NIRS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
733 participants
Where
1 siteFrance
Study dates
7 Jun 2012to 8 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • major
  • socially insured persons
  • given their consent.
  • absence of contraindication to the MRI examination

Who cannot join

  • Subjects under the age of 18
  • pregnant women
  • all other persons referred to in articles L1121-5 to L1121-8 of the CSP

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Grenoble-Alpes

    Grenoble, 38043

Other trials in France

About this study

The main objective of the studies that will be carried out on volunteer patients who have given their consent will be the development and optimization of the sequence parameters or the design of the stimulation paradigms in order to optimize the quality and Relevance of the images realized taking into account anatomical, functional or metabolic parameters. These adjustments will be carried out without interfering with the management of voluntary patients

Read the detailed description

The pathologies that interest us in these refinements concern mainly the chronic (or sequellar) brain disorders which can be degenerative, developmental or vascular. The patients who will be recruited will be known patients of our Service (University Clinic of Neuroradiology and MRI) that we follow during checks. The type of examination that will be applied to them, between MRI, EEG and NIRS, will be specified in the consent form. These examinations will not be invoiced either to the patient or to the social security, and the related costs will be borne by our Federative Research Structure or sometimes, when these explorations are upstream of a defined research protocol and funded, They will be financed under this protocol.

Being tested
MRI, EEG, NIRS

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIRadiation

  • EEGDevice

  • NIRSDevice

Study groups in NCT03152539
Study groupRoleWhat they receive
Development of MRI protocolsExperimentalMRI exam to grade differents interventions for future research
Receives: Radiation: MRI
Development of EEG protocolsExperimentalEEF exam to grade differents interventions for future research
Receives: Device: EEG
Development of NIRS protocolsExperimentalNIRS exam to grade differents interventions for future research
Receives: Device: NIRS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Spatial resolution of new MRI imaging sequences MRI scanning.

    Measured: Two hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 May 2017
  2. Study start7 Jun 2012
  3. Primary completion8 Jul 2021
  4. Study completion8 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Single group
Model description
Methodological development of new MRI approaches
Masking
None (open label)
Enrolment
733 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03152539
Sponsor's protocol ID
38RC12.238
Acronym
MAP-VS
Status last verified
Oct 2021
First submitted
24 Apr 2017
Last updated
20 Oct 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MRI, EEG and NIRS in people with Magnetic Resonance Imaging, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Spatial resolution of new MRI imaging sequences MRI scanning. (time frame: Two hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in